Bristol-Myers to buy heart drugs developer MyoKardia for about $13 billion

This post was originally published on this site

https://i-invdn-com.akamaized.net/news/LYNXMPEBBR0PM_M.jpg

Bristol Myers will pay $225 per share in cash, a 61.2% premium to MyoKardia’s Friday closing price.

Add Comment